Xeljanz (tofacitinib) approved for treatment of ulcerative colitis

Last updated: 01 November 2019

You can legally access new medicines, even if they are not approved in your country.

Learn more »

Moderately to severely active ulcerative colitis can now be treated with tofacitinib following an expanded approval by the FDA.

This will provide a much-needed alternative therapy for a debilitating disease with limited treatment options. To find out about ulcerative colitis and how this medicine works please read the full FDA article.